⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Ramipril

رامی‌پریل

⚠ Unverified

❤️ Cardiovascular SystemACE inhibitor

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Use with caution 👶 Children:Safety not established 👴 Older adults:Use with caution 🇮🇷 Registered in Iran ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA091604 ATC C09AA05

Market / country: 🇺🇸 USA

Altace (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Ramipril · 2.1

• Maintenance 2.5–20 mg/day once or in two doses. FDA Ramipril · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity or angioedema with any ACE inhibitor; with sacubitril; aliskiren in diabetes. FDA Ramipril · 4
⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Ramipril · Boxed Warning

Formulations

1.25 mg capsule — capsule 🇺🇸 USA FDA Ramipril · 3
2.5 mg capsule — capsule 🇺🇸 USA FDA Ramipril · 3
5 mg capsule — capsule 🇺🇸 USA FDA Ramipril · 3
10 mg capsule — capsule 🇺🇸 USA FDA Ramipril · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Ramipril · Boxed Warning
“WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Ramipril · 8.3
“Ingestion of a single 10 mg oral dose of ramipril resulted in undetectable amounts of ramipril and its metabolites in breast milk.”
👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Ramipril · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ramipril · 8.5
“Of the total number of patients who received ramipril in U.S. clinical studies of ramipril, 11% were ≥65 years of age while 0.2% were ≥75 years of age.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA091604
DailyMed (FDA label)FDA Ramipril
MedlinePlus (NIH)Ramipril
WHO ATC/DDDC09AA05
Darooyab (Iran)Ramipril

🇮🇷 Registered in Iran Darooyab · G-1865/Ramipril

Dosage forms with Iranian generic codes, per Darooyab.

08849 · RAMIPRIL 1.25MG TAB · قرص رامیپریل ۱٫۲۵ میلی‌گرم
06487 · RAMIPRIL 10MG TAB · قرص رامیپریل ۱۰ میلی‌گرم
08046 · RAMIPRIL 2.5MG CAP · کپسول رامیپریل ۲٫۵ میلی‌گرم
07701 · RAMIPRIL 2.5MG TAB · قرص رامیپریل ۲٫۵ میلی‌گرم
07705 · RAMIPRIL 5MG TAB · قرص رامیپریل ۵ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Ramipril · 3 FDA Ramipril · 2.1 FDA Ramipril · 2.2 FDA Ramipril · 2.3 FDA Ramipril · 2 FDA Ramipril · 4 FDA Ramipril · Boxed Warning FDA Ramipril · 8.3 FDA Ramipril · 8.4 FDA Ramipril · 8.5 FDA Ramipril · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1865/Ramipril
Clinical review⚠ Unverified